A Novel AP-1 Element in the CD95 Ligand Promoter Is Required for Induction of Apoptosis in Hepatocellular Carcinoma Cells upon Treatment with Anticancer Drugs
Sören T. Eichhorst(National Center for Tumor Diseases), Peter H. Krammer(Slovak Academy of Sciences), Peter Angel(Heidelberg University), Min Li‐Weber(German Cancer Research Center), Henning Schulze‐Bergkamen(Heidelberg University), Martina Müller(University Hospital Regensburg)
Cited by 140
Related Papers
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
|Nature|1995|1.6k